So-Young International Inc.
SYSo-Young International Inc. in brief
So-Young International Inc. is a listed company in the Healthcare Information Services industry, based in Beijing, China. Its market value was $225 M on 1 August 2026, which makes it the 15,814th largest listed company in the world and the 4,006th largest in China on this site. In the year to December 2025 it had sales of $218 M and a net loss of $35 M. Its largest product and service lines by sales in 2025 were Aesthetic Treatment Services (44%) and Sales of medical products and maintenance services (19%). Its shares trade under the symbol SY (Nasdaq).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About So-Young International Inc.
We have established stringent controls and procedures for cash flows within our organization. Each transfer of cash between our Cayman Islands holding company and a subsidiary, the consolidated affiliated entities or the subsidiaries of the consolidated affiliated entities is subject to internal approval. The cash inflows of the Cayman Islands holding company were primarily generated from the proceeds we received from our public offerings of ordinary shares, historical financing activities and cash provided by our operating activities. In 2023, 2024 and 2025, the Cayman Islands holding company transferred cash in the total amount of RMB38.0 million, RMB74.6 million and RMB28.3 million (US$4.0 million) to our subsidiaries in mainland China, the consolidated affiliated entities and their subsidiaries through our offshore intermediate holding entities. For the years ended December 31, 2023, 2024 and 2025, no assets other than cash were transferred between the Cayman Islands holding company and a subsidiary, a consolidated affiliated entity or its subsidiary and no subsidiaries paid dividends or made other distributions to the holding company. The VIEs have paid RMB264.1 million, RMB231.1 million and RMB189.4 million (US$27.0 million) of service fee to the wholly-owned subsidiary in mainland China under the VIE arrangements for the years ended December 31, 2023, 2024 and 2025, respectively. The VIEs expect to continue to settle any service fees incurred under the Exclusive Business Cooperation Agreements.
From the company's annual report filed with the US SEC: read the report
So-Young International Inc. timeline
- 2018
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 2019
- 🔔Initial public offering on NasdaqFinal prospectus filed with the SEC on 2 May 2019; shares registered for exchange trading on 22 April 2019.
- 2021
- 💰Record revenue of $266 millionFY2021, the highest of the 7 years on record.
Events of So-Young International Inc. from SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in China: #1,312 (Jan 2020) · #1,663 (Jan 2021) · #4,401 (Jan 2022) · #4,922 (Dec 2022) · #4,947 (Jul 2023) · #5,058 (Jan 2024) · #4,376 (Mar 2026) · #4,023 (Aug 2026)
Key ratios
- P/E ratio (TTM)
- n/m (loss)
- Price / sales (TTM)
- 1.0×
- Price / book
- 1.0×
- Free cash flow yield
- -19.2%
- Net margin (TTM)
- -15.9%
- Operating margin
- -18.8%
- Return on equity
- -15.6%
- Liabilities / assets
- 37.0%
- Revenue growth
- +8.4%
- R&D / revenue
- 9.0%
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $218M | +8.4% | $-41M | $-35M | -15.9% |
| Dec 2024 | $201M | -4.8% | $-86M | $-81M | -40.2% |
| Dec 2023 | $211M | +15.7% | $-9M | $3M | 1.4% |
| Dec 2022 | $182M | -31.3% | $-15M | $-10M | -5.2% |
| Dec 2021 | $266M | +33.8% | $-5M | $-1M | -0.5% |
| Dec 2020 | $198M | +20.0% | $-9M | $1M | 0.4% |
| Dec 2019 | $165M | +331.1% | $21M | $25M | 15.3% |
| Dec 2017 | $38M | — | $4M | $3M | 6.6% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2025 | $-15M | $28M | $-43M | — | — |
| Dec 2024 | $-4M | $9M | $-12M | — | — |
| Dec 2023 | $3M | $7M | $-4M | — | — |
| Dec 2022 | $-16M | $2M | $-19M | — | — |
| Dec 2021 | $13M | $7M | $6M | — | — |
| Dec 2020 | $27M | $6M | $22M | — | — |
| Dec 2019 | $55M | $5M | $50M | — | — |
| Dec 2017 | $13M | $0M | $13M | — | — |
SEC filings
- Aug 31, 20266-KReport of foreign issuer
- Aug 4, 20266-KReport of foreign issuer
- May 22, 20266-KReport of foreign issuer
- Apr 23, 202620-FAnnual report (foreign issuer) · period to Dec 2025
- Mar 25, 20266-KReport of foreign issuer
- Feb 13, 20266-KReport of foreign issuer
- Dec 31, 20256-KReport of foreign issuer
- Nov 17, 20256-KReport of foreign issuer
- Aug 15, 20256-KReport of foreign issuer
- Jul 3, 20256-KReport of foreign issuer
- Jun 20, 20256-KReport of foreign issuer
- Jun 6, 20256-KReport of foreign issuer
Official filings of So-Young International Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- $218 M
- Operating income
- $-41 M
- Net income
- $-35 M
For year ending December-2025 · source: SEC filing
Balance sheet
- Total assets
- $379 M
- Total liabilities
- $140 M
- Total equity
- $222 M
As of December-2025
Top 24 institutional investors in So-Young International Inc.#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | TB Alternative Assets Ltd. | 3,067,873 | 0 (0.00%) | 2.51% | $8 M | Oct 16, 2026 |
| 2 | Barclays PLC | 1,129,166 | 0 (0.00%) | 0.92% | $3 M | Nov 6, 2026 |
| 3 | Citigroup Inc | 1,035,309 | 0 (0.00%) | 0.85% | $3 M | Nov 4, 2026 |
| 4 | Morgan Stanley | 724,295 | -507,442 (-41.20%) | 0.59% | $2 M | Nov 13, 2026 |
| 5 | UBS Group AG | 230,868 | -215,685 (-48.30%) | 0.19% | $1 M | Nov 10, 2026 |
| 6 | State Street Corp | 158,125 | -232,826 (-59.55%) | 0.13% | $0 M | Nov 12, 2026 |
| 7 | Dimensional Fund Advisors LP | 60,904 | -165,766 (-73.13%) | 0.05% | $0 M | Nov 4, 2026 |
| 8 | Invesco Ltd. | 50,526 | +249 (+0.50%) | 0.04% | $0 M | Nov 12, 2026 |
| 9 | Nomura Holdings Inc | 35,400 | -71,800 (-66.98%) | 0.03% | $0 M | Nov 16, 2026 |
| 10 | Verition Fund Management LLC | 33,060 | 0 (0.00%) | 0.03% | $0 M | Nov 13, 2026 |
| 11 | Geode Capital Management, LLC | 31,572 | -24,285 (-43.48%) | 0.03% | $0 M | Nov 6, 2026 |
| 12 | SmartHarvest Portfolios, LLC | 30,958 | New | 0.03% | $0 M | Oct 26, 2026 |
| 13 | Jane Street Group, LLC | 17,078 | -94,923 (-84.75%) | 0.01% | $0 M | Nov 12, 2026 |
| 14 | Two Sigma Investments, LP | 15,900 | -900 (-5.36%) | 0.01% | $0 M | Nov 16, 2026 |
| 15 | Citadel Advisors LLC | 13,105 | -29,640 (-69.34%) | 0.01% | $0 M | Nov 16, 2026 |
| 16 | Ewa, LLC | 12,807 | -439 (-3.31%) | 0.01% | $0 M | Nov 17, 2026 |
| 17 | Simplex Trading, LLC | 7,842 | -13,588 (-63.41%) | 0.01% | $0 M | Nov 4, 2026 |
| 18 | SBI Securities Co., Ltd. | 5,026 | 0 (0.00%) | 0.00% | $0 M | Oct 22, 2026 |
| 19 | Rhumbline Advisers | 4,011 | 0 (0.00%) | 0.00% | $0 M | Nov 10, 2026 |
| 20 | Tower Research Capital LLC (TRC) | 3,920 | -23,843 (-85.88%) | 0.00% | $0 M | Nov 16, 2026 |
| 21 | Group One Trading LLC | 1,283 | New | 0.00% | $0 M | Nov 10, 2026 |
| 22 | Caitong International Asset Management Co., Ltd | 1,267 | +1,257 (+12570.00%) | 0.00% | $0 M | Oct 29, 2026 |
| 23 | Osaic Holdings, Inc. | 785 | 0 (0.00%) | 0.00% | $0 M | Nov 12, 2026 |
| 24 | Nisa Investment Advisors, LLC | 11 | New | 0.00% | $0 M | Oct 20, 2026 |
Mutual funds holding So-Young International Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 Invesco Golden Dragon China ETFInvesco Capital Management LLC | 57,257 | $0 M | 0.05% | 0.15% | — | Apr 30, 2026 |
| 🇺🇸 The Emerging Markets Small Cap SeriesDimensional Fund Advisors LP | 92,288 | $0 M | 0.08% | <0.01% | −0.2% | Jul 31, 2026 |
| 🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC | 55,857 | $0 M | 0.05% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 State Street SPDR S&P Emerging Markets Small Cap ETFSSGA Funds Management, Inc. | 29,782 | $0 M | 0.02% | <0.01% | −8.6% | Jun 30, 2026 |
| 🇺🇸 Emerging Markets Social Core Equity PortfolioDimensional Fund Advisors LP | 23,558 | $0 M | 0.02% | <0.01% | +36% | Jul 31, 2026 |
| 🇺🇸 Emerging Markets Core Equity 2 PortfolioDimensional Fund Advisors LP | 18,599 | $0 M | 0.02% | <0.01% | −52% | Jul 31, 2026 |
| 🇺🇸 State Street SPDR S&P China ETFSSGA Funds Management, Inc. | 13,369 | $0 M | 0.01% | <0.01% | −3.8% | Jun 30, 2026 |
| 🇺🇸 Avantis Emerging Markets Small Cap Equity ETFAmerican Century ETF Trust | 1,474 | $0 M | <0.01% | <0.01% | no change | May 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 8 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Insider trading at So-Young International Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Gefei LiCOO, Director | Option exercise | +23,076 | 0.010 | 231local | 69,229 | Form 4 |
| filed | Bei WangCMO, Director | Option exercise | +30,260 | 0.010 | 303local | 141,940 | Form 4 |
| filed | Gefei LiCOO, Director | Option exercise | +46,153 | 0.010 | 462local | 46,153 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals. This company files with the SEC as a foreign issuer; its insiders often report prices in the home currency, so amounts are as filed and not converted to dollars
Markets and events: So-Young International Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
Fails to deliver
- : 30,727 shares at $2.01
- : 295 shares at $2.10
- : 13 shares at $2.11
- : 1,128 shares at $2.13
- : 297 shares at $2.25
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
So-Young International Inc. scorecard#
Passes 5 of the 16 checks that could be worked out: strongest in shareholder returns (2 of 3), weakest in profitability (0 of 5). Fiscal year 2025; market cap of Aug 1, 2026.
Valuationnot known
- –P/E below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
- –Price to book below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
- –Price to sales below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
- –Free cash flow yield above 5%The market cap dates from 2026-08-01, more than 60 days ago.
- –Earnings yield above the 10-year Treasury yieldThe market cap dates from 2026-08-01, more than 60 days ago.
- –The price assumes slower growth than the last three years'The market cap dates from 2026-08-01, more than 60 days ago.
Growth2 of 5
- ✓Revenue grew in the newest year8.4%Revenue up 8.4% in fiscal 2025.
- ✓Revenue up more than 5% a year over three years6.1%6.1% a year over the three years to fiscal 2025.
- ✗Faster growth over three years than its peers' median6.1%6.1% a year against Healthcare Information Services's median of 6.1% (27 companies).
- –Earnings per share grew in the newest yearEarnings per share of two years are not on file.
- ✗Net income higher than five years earlier-$35 M-$35 M in fiscal 2025 against $1 M in 2020.
- ✗Revenue rose in at least four of the last five years3 of 5Revenue rose in 3 of the five years to fiscal 2025.
Profitability0 of 5
- ✗Profitable in the newest year-$35 MNet income -$35 M in fiscal 2025.
- ✗Profitable in each of the last five years1 of 5Profitable in 1 of the five years to fiscal 2025.
- ✗Operating margin above its peers' median-18.8%-18.8% against Healthcare Information Services's median of -7.1% (29 companies).
- ✗Return on equity above 15%-14.6%-14.6% in fiscal 2025.
- –Return on invested capital above 10%No return on invested capital on file.
- ✗Operating margin wider than three years earlier-18.8%-18.8% in fiscal 2025 against -8.2% in 2022.
Financial health1 of 3
- ✓Short-term assets cover short-term liabilities1.9×Current ratio 1.89 at the end of fiscal 2025.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- –Operating income covers interest five timesInterest expense is not on file.
- ✗Cash from operations positive in each of the last three years1 of 3Positive in 1 of the three years to fiscal 2025.
- ✗Altman Z-score outside the distress zone0.88Z-score 0.88 (distress zone) for fiscal 2025.
Shareholder returns2 of 3
- ✓Pays a dividendYesPaid dividends in fiscal 2025.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomeNo payout ratio (a loss year).
- ✓Share count up no more than 2% in a year-1.9%Diluted shares down 1.9% in fiscal 2025.
- –Dividends and buybacks above 3% of the market valueThe market cap dates from 2026-08-01, more than 60 days ago.
- ✗Free cash flow covers dividends and buybacks-$43 MFree cash flow -$43 M against $5 M paid out in fiscal 2025.
Worked out from the statements as filed (sec), the medians of Healthcare Information Services, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2025#
Worked out from So-Young International Inc.'s statements, beside the median of Healthcare Information Services.
| Ratio | Trend | 2025 | Median of peers |
|---|---|---|---|
| Operating margin | -18.8% | -7.1% | |
| Net margin | -15.9% | -6.8% | |
| Return on equity | -14.6% | -0.8% | |
| Revenue growth, 3 years a year | 6.1% | 6.1% | |
| Revenue growth | 8.4% | 8.7% | |
| Free cash flow margin | -19.8% | 14.1% |
4of 8on the Piotroski tests of financial strength
- Net loss of $35 million.
- Free cash flow was negative: -$43 million.
So-Young International Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in CNY millions; per-share figures in CNY; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Dec 31, 2025 | FY 2024to Dec 31, 2024 | FY 2023to Dec 31, 2023 | FY 2022to Dec 31, 2022 | FY 2021to Dec 31, 2021 | FY 2020to Dec 31, 2020 | FY 2019to Dec 31, 2019 | FY 2018to Dec 31, 2018 | FY 2017to Dec 31, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 1,523+3.9%100% | 1,467−2.1%100% | 1,498+19.1%100% | 1,258−25.7%100% | 1,692+30.7%100% | 1,295+12.4%100% | 1,152+86.6%100% | 617+138%100% | 259—100% | |
| Cost of revenue | 796+40.2%52.2% | 568+4.3%38.7% | 544+38.4%36.3% | 393+19.9%31.3% | 328+54.5%19.4% | 212+6.8%16.4% | 199+117%17.2% | 92+104%14.8% | 45—17.3% | |
| Gross profit | 728−19.1%47.8% | 899−5.7%61.3% | 954+10.3%63.7% | 865−36.6%68.7% | 1,365+26.0%80.6% | 1,083+13.6%83.6% | 953+81.3%82.8% | 526+145%85.2% | 215—82.7% | |
| Research and development | 137−17.0%9.0% | 165−18.9%11.3% | 204−13.4%13.6% | 235−18.0%18.7% | 287+25.0%16.9% | 229+29.3%17.7% | 177+87.1%15.4% | 95+191%15.3% | 33—12.6% | |
| Selling and marketing | — | 494−5.0%33.7% | 520+10.2%34.7% | 472−40.4%37.5% | 792+9.1%46.8% | 726+54.5%56.1% | 470+53.4%40.8% | 306+140%49.6% | 127—49.2% | |
| General and administrative | — | 324+11.5%22.1% | 291+11.7%19.4% | 260+3.2%20.7% | 252+37.1%14.9% | 184+14.6%14.2% | 161+113%13.9% | 75+154%12.2% | 30—11.5% | |
| Operating expenses | 1,014−33.5%66.6% | 1,524+50.1%104% | 1,015+4.9%67.7% | 967−30.8%76.9% | 1,397+22.6%82.6% | 1,139+41.1%88.0% | 808+69.5%70.1% | 477+151%77.2% | 190—73.2% | |
| Operating income | −286—−18.8% | −624—−42.6% | −61—−4.1% | −103—−8.2% | −33—−1.9% | −57−139%−4.4% | 145+195%12.6% | 49+98.4%8.0% | 25—9.5% | |
| Interest and finance income | 24−49.3%1.5% | 47−4.8%3.2% | 49+69.1%3.3% | 29+49.4%2.3% | 19−51.3%1.1% | 40−11.9%3.1% | 45+314%3.9% | 11+6082%1.8% | 0.2—0.1% | |
| Provision for credit losses | 21−46.4%1.4% | 40+154%2.7% | 16+18.2%1.0% | 13—1.1% | — | — | — | — | — | |
| Share of profit of associates | −4.1—−0.3% | −15—−1.0% | −13—−0.8% | −17—−1.4% | −1.5—−0.1% | −4.3—−0.3% | — | — | −3.9—−1.5% | |
| Other non-operating income (expense) | 13+1041%0.8% | 1.1−94.8%0.1% | 22+166%1.5% | 8.2−31.5%0.7% | 12+35.1%0.7% | 8.9−74.4%0.7% | 35+3413%3.0% | 1.0—0.2% | −12—−4.7% | |
| Income before tax | −246—−16.2% | −588−7573%−40.1% | 7.9—0.5% | −87—−6.9% | −16−17740%−1.0% | 0.1−100.0%0.0% | 226+289%19.7% | 58+341%9.4% | 13—5.1% | |
| Income tax | 0.8—0.1% | −0.9—−0.1% | −18—−1.2% | −21−199%−1.7% | 21—1.3% | −4.8−110%−0.4% | 50+1468%4.3% | 3.2—0.5% | −4.0—−1.5% | |
| Net income including minority interests | −247—−16.2% | −587−2363%−40.0% | 26—1.7% | −66—−5.3% | −38−872%−2.2% | 4.9−97.2%0.4% | 177+221%15.3% | 55+220%8.9% | 17—6.6% | |
| Minority interests' share of net income | −4.6−296%−0.3% | 2.3−49.7%0.2% | 4.7—0.3% | −0.6—−0.0% | −29—−1.7% | −0.9—−0.1% | — | — | — | |
| Net income attributable to shareholders | −242—−15.9% | −590−2870%−40.2% | 21—1.4% | −66—−5.2% | −8.4−244%−0.5% | 5.8−96.7%0.4% | 177+221%15.3% | 55+220%8.9% | 17—6.6% | |
| Shares, weighted average (basic) | 78−1.9%— | 79+2.2%— | 78−6.1%— | 83+1.2%— | 82+0.2%— | 82+37.4%— | 59+142%— | 25−8.7%— | 27—— | |
| Shares, weighted average (diluted) | 78−1.9%— | 79+1.7%— | 78−5.6%— | 83+1.2%— | 82−2.5%— | 84+32.3%— | 63+158%— | 25−8.7%— | 27—— | |
| Balance sheet | ||||||||||
| Cash and cash equivalents | 418−28.8%15.8% | 588+37.9%21.5% | 426−38.6%13.3% | 694−47.9%21.7% | 1,332+18.2%40.0% | 1,127+27.4%34.2% | 885+57.0%27.4% | 563+27.8%42.0% | 441—— | |
| Receivables | 52−47.8%1.9% | 99+72.6%3.6% | 57+58.9%1.8% | 36−34.3%1.1% | 55+3.7%1.6% | 53+102%1.6% | 26+149%0.8% | 10—0.8% | — | |
| Inventory | 233+53.8%8.8% | 152+27.6%5.5% | 119−1.3%3.7% | 120+31.2%3.8% | 92—2.8% | — | — | — | — | |
| Other current assets | 9.4−5.9%0.4% | 9.9+64.9%0.4% | 6.0+153%0.2% | 2.4r1.9−22.5%0.1% | 3.1+1010%0.1% | 0.3+669%0.0% | 0.0−92.0%0.0% | 0.5—0.0% | — | |
| Current assets | 1,485−13.9%56.0% | 1,724+0.1%63.0% | 1,722−10.2%53.6% | 1,917−5.5%59.9% | 2,027−27.5%60.9% | 2,796−5.4%84.9% | 2,957+131%91.6% | 1,278—95.4% | — | |
| Property, plant and equipment | 294+89.0%11.1% | 155+33.0%5.7% | 117+0.5%3.6% | 116−6.7%3.6% | 125+318%3.7% | 30−7.8%0.9% | 32+894%1.0% | 3.3—0.2% | — | |
| Right-of-use (leased) assets | 252+54.6%9.5% | 163+37.5%6.0% | 118+88.3%3.7% | 63−34.2%2.0% | 96−20.4%2.9% | 120−16.9%3.6% | 144—4.5% | — | — | |
| Goodwill | 0.70.0%0.0% | 0.7−99.9%0.0% | 5410.0%16.8% | 5410.0%16.9% | 541+1015%16.2% | 49—1.5% | — | — | — | |
| Other intangible assets | 144+13.8%5.4% | 127−12.8%4.6% | 145−14.2%4.5% | 169−12.7%5.3% | 194+223%5.8% | 60+8168%1.8% | 0.7—0.0% | — | — | |
| Investments in associates | 22−17.4%0.8% | 27+20.8%1.0% | 22+603%0.7% | 3.1−84.5%0.1% | 20+120%0.6% | 9.2−31.8%0.3% | 13—0.4% | — | — | |
| Long-term investments | 275−2.0%10.4% | 280+7.4%10.2% | 261+14.5%8.1% | 228−9.7%7.1% | 253+52.0%7.6% | 166+261%5.0% | 46+210%1.4% | 15+162%1.1% | 5.7—— | |
| Non-current assets | 1,165+15.3%44.0% | 1,011−32.3%37.0% | 1,493+16.5%46.4% | 1,281−1.7%40.1% | 1,303+163%39.1% | 496+81.7%15.1% | 273+340%8.4% | 62—4.6% | — | |
| Total assets | 2,650−3.1%100% | 2,735−14.9%100% | 3,215+0.5%100% | 3,198−4.0%100% | 3,330+1.2%100% | 3,292+1.9%100% | 3,230+141%100% | 1,341—100% | — | |
| Accounts payable | 27+32.9%1.0% | 20+92.2%0.7% | 11−20.0%0.3% | 13−29.9%0.4% | 19—0.6% | — | — | — | — | |
| Current liabilities | 784+24.4%29.6% | 630+16.6%23.0% | 540+0.4%16.8% | 538−24.5%16.8% | 712+24.8%21.4% | 571+22.4%17.3% | 467+54.4%14.4% | 302—22.5% | — | |
| Lease liabilities (non-current) | 183+46.5%6.9% | 125+45.2%4.6% | 86+311%2.7% | 21−66.4%0.7% | 62−33.0%1.9% | 93−23.0%2.8% | 121—3.7% | — | — | |
| Non-current liabilities | 197+34.6%7.4% | 146+29.6%5.3% | 113+117%3.5% | 52−48.5%1.6% | 101−0.6%3.0% | 102−15.9%3.1% | 121—3.7% | — | — | |
| Total liabilities | 981+26.3%37.0% | 776+18.9%28.4% | 653+10.7%20.3% | 590−27.5%18.4% | 813+21.0%24.4% | 672+14.5%20.4% | 587+94.4%18.2% | 302—22.5% | — | |
| Retained earnings | −1,175—−44.3% | −926—−33.9% | −330—−10.3% | −347—−10.8% | −272—−8.2% | −254—−7.7% | −259—−8.0% | −394—−29.4% | — | |
| Shareholders' equity | 1,553−15.5%58.6% | 1,839−24.8%67.2% | 2,444−2.2%76.0% | 2,498+2.1%78.1% | 2,446−5.8%73.5% | 2,596−1.8%78.9% | 2,643—81.8% | −358—−26.7% | −167—— | |
| Minority interests | 116−3.4%4.4% | 120+2.1%4.4% | 117+6.6%3.6% | 110+55.2%3.4% | 71—2.1% | — | — | — | — | |
| Total equity | 1,669−14.8%63.0% | 1,959−23.5%71.6% | 2,561−1.8%79.7% | 2,608+3.6%81.6% | 2,517−3.1%75.6% | 2,596−1.8%78.9% | 2,643—81.8% | — | — | |
| Total liabilities and equity | 2,650−3.1%100% | 2,735−14.9%100% | 3,215+0.5%100% | 3,198−4.0%100% | 3,330+1.2%100% | 3,292+1.9%100% | 3,230+141%100% | 1,341—100% | — | |
| Shares outstanding | — | — | — | — | — | 70—— | — | — | — | |
| Cash-flow statement | ||||||||||
| Depreciation and amortization | 57+24.6%3.8% | 46−0.4%3.1% | 46−2.1%3.1% | 47+56.5%3.7% | 30+114%1.8% | 14+130%1.1% | 6.1+268%0.5% | 1.7+169%0.3% | 0.6—0.2% | |
| Share-based compensation | 8.9−72.7%0.6% | 33−10.1%2.2% | 36−16.2%2.4% | 43−59.2%3.4% | 106+15.2%6.3% | 92−11.6%7.1% | 104+303%9.0% | 26+873%4.2% | 2.7—1.0% | |
| Cash from operating activities | −105—−6.9% | −26−214%−1.7% | 23—1.5% | −113−234%−9.0% | 84−53.0%5.0% | 179−53.3%13.8% | 384+92.9%33.3% | 199+119%32.2% | 91—35.0% | |
| Capital expenditure | −197—−12.9% | −63—−4.3% | −51—−3.4% | −16—−1.2% | −45—−2.7% | −37—−2.9% | −38—−3.3% | −6.4—−1.0% | −0.2—−0.1% | |
| Acquisitions, net of cash acquired | — | — | — | −97—−7.8% | −637—−37.6% | −41—−3.2% | — | — | — | |
| Cash from investing activities | −43−117%−2.8% | 257—17.5% | −203—−13.5% | −572−268%−45.5% | 340+174%20.1% | 124—9.6% | −1,335—−116% | −569−8197%−92.2% | 7.0—2.7% | |
| Shares bought back | −15—−1.0% | −18—−1.2% | −126—−8.4% | −15—−1.2% | −218—−12.9% | — | — | — | — | |
| Dividends paid | −19—−1.2% | −44—−3.0% | — | — | — | — | — | — | — | |
| Cash from financing activities | −64—−4.2% | −22—−1.5% | −100—−6.7% | −14—−1.1% | −217—−12.8% | −5.8−100%−0.4% | 1,268+161%110% | 485+49.5%78.6% | 325—125% | |
| Exchange-rate effect on cash | — | — | — | — | −9.2—−0.5% | −53−356%−4.1% | 21+175%1.8% | 7.5—1.2% | −0.1—−0.0% | |
| Change in cash | −213−200%−14.0% | 213—14.5% | −268—−17.9% | −643−424%−51.1% | 198−19.0%11.7% | 245−27.6%18.9% | 338+176%29.3% | 123−71.0%19.9% | 422—163% | |
| Report | 20-F | 20-F | 20-F | 20-F | 20-F | 20-F | 20-F | 20-F | 20-F | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Dec 31, 2025. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
What So-Young International Inc. sells: revenue by product line, fiscal 2025#
As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.
Products and services
- Aesthetic Treatment Services$94 M44%+299%
- Sales of medical products and maintenance services$40 M19%-23%
- Other services$11 M5.3%-58%
Business segments
- Aesthetic treatment services group$94 M44%+299%
- Platform service group$70 M32%-32%
- Wuhan Miracle$28 M13%-26%
Source: SEC annual report (XBRL data) · as of Dec 31, 2025
How So-Young International Inc. compares in Healthcare Information Services
- Market cap$225 M · higher than 22% of 37
- Revenue$218 M · higher than 42% of 70
- Net margin-15.9% · higher than 31% of 68
- Revenue growth8.4% · higher than 46% of 38
- Price / sales1.0× · lower than 81% of 28
- Price / book1.0× · lower than 78% of 28
- FCF yield-19.2% · higher than 10% of 21
- 🇺🇸 American Well Corporation$233 M
- 🇺🇸 OptimizeRx Corporation$165 M
- 🇨🇦 Vitalhub Corp.$354 M
- 🇺🇸 Health Catalyst, Inc.$139 M
- 🇺🇸 Evolent Health, Inc.$383 M
- 🇹🇼 Onyx Healthcare Inc.$96 M
Peer comparison · Healthcare Information Services
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| So-Young International Inc.🇨🇳 | $225 M | — | -15.9% | +8.4% |
| Veeva Systems Inc.🇺🇸 | $50.2 B | 49.5× | 29.4% | +16.3% |
| Pro Medicus Limited🇦🇺 | $14.4 B | 81.3× | — | — |
| 10x Genomics, Inc.🇺🇸 | $9.4 B | — | -10.8% | +5.3% |
| HealthEquity, Inc.🇺🇸 | $8.3 B | 35.3× | 17.4% | +9.5% |
| M3, Inc.🇯🇵 | $7.1 B | 21.5× | 14.0% | — |
| Doximity, Inc.🇺🇸 | $5.5 B | 39.5× | 21.1% | +13.1% |
| Privia Health Group, Inc.🇺🇸 | $2.8 B | 80.9× | 1.4% | +22.3% |
| Winning Health Technology Group Co., Ltd.🇨🇳 | $2.3 B | 41.3× | 13.8% | — |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- American Well Corporation$233 M
- OptimizeRx Corporation$165 M
- Vitalhub Corp.$354 M
- Health Catalyst, Inc.$139 M
- Evolent Health, Inc.$383 M
- Onyx Healthcare Inc.$96 M
Sources and freshness
- Market cap:
- Aug 1, 2026
- Annual results:
- For year ending December-2025
- Balance sheet:
- As of December-2025
- Profile updated:
- Nov 20, 2026
Figures from Market data, SEC filing, value.today research, SEC annual report; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at So-Young International Inc.? Verify and update this profile — free
Show So-Young International Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.